13 Aug 2020 07:07
Arix Bioscience Plc - Notice of ResultsArix Bioscience Plc - Notice of Results
PR Newswire
London, August 13
Arix Bioscience plc
Notice of Interim Results
LONDON, 13 August 2020: Arix Bioscience plc (“Arix” or the “Company”) (LSE: ARIX), a global venture capital company focused on investing in and building breakthrough biotech companies, will announce its interim results for the six months ended 30 June 2020, on Tuesday 8 September 2020.
Arix will publish a pre-recorded presentation on the same day, at 7.00am BST, followed by a Q&A session accessible via conference call or webcast at 12.30pm BST. The webcast of the presentation will be available on the Company's investor relations website at https://arixbioscience.com/investor-relations/results-centre.
[ENDS]
Enquiries
For more information on Arix, please contact:
Arix Bioscience plcCharlotte Parry, Head of Investor Relations+44 (0) 20 7290 1072charlotte@arixbioscience.com
Optimum Strategic CommunicationsMary Clark, Supriya Mathur, Shabnam BashirT: +44 (0) 20 3950 9144optimum.arix@optimumcomms.com
About Arix Bioscience plc
Arix Bioscience plc is a global venture capital company focused on investing in and building breakthrough biotech companies around cutting edge advances in life sciences.
We collaborate with exceptional entrepreneurs and provide the capital, expertise and global networks to help accelerate their ideas into important new treatments for patients. As a listed company, we are able to bring this exciting growth phase of our industry to a broader range of investors.